<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Cell. Author manuscript; available PMC 2013 October 25. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Cell. 2013 April 25; 153(3): 614&#226;&#8364;&#8220;627. doi:10.1016/j.cell.2013.03.040. <br />  <br />  <br />  <br />                            Proteasome regulation <span id='am-6' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>ADP</span>-ribosylation <br />                            Park F. Cho-Park Hermann Steller* <br />                            Strang Laboratory Apoptosis Cancer Biology, Howard Hughes Medical Institute,                            Rockefeller University, 1230 York Avenue, New York, NY 10021, USA <br />  <br />                            Summary <br />                                  Protein degradation ubiquitin-proteasome central cell homeostasis survival. <br />                                  Defects process associated diseases cancer neurodegenerative <br />                                  disorders. 26S proteasome large protease complex degrades ubiquitinated proteins. <br />                                  ADP-ribosylation promotes 26S proteasome activity Drosophila                                  human cells. identify ADP-ribosyl transferase Tankyrase (TNKS) 19S assembly <br />                                  chaperones dp27 dS5b direct binding partners proteasome regulator PI31. TNKS- <br />                                  mediated ADP-ribosylation PI31 drastically reduces affinity 20S proteasome &#206;&#177;-subunits <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  relieve 20S repression PI31. Additionally, PI31 modification increases binding                                  sequestration dp27 dS5b 19S regulatory particles, promoting 26S assembly. Inhibition <br />                                  TNKS RNAi small-molecule inhibitor, XAV939, blocks process reduce <br />                                  26S assembly. results unravel mechanism proteasome regulation targeted <br />                                  existing small-molecule inhibitors. <br />  <br />  <br />                            Introduction <br />                                              Selective protein degradation plays central role removal misfolded, potentially <br />                                              toxic proteins, control cell cycle progression, regulation gene expression,                                              changes cell size morphology (Baumeister et al., 1998; Demartino Gillette, 2007; <br />                                              Finley, 2009; Glickman Ciechanover, 2002; Hershko, 2005; Hershko Ciechanover, <br />                                              1998; Murata et al., 2009; Tanaka et al., 2012).  abnormal protein degradation                                              associated wide range human diseases, cancer, muscle wasting diseases <br />                                              neurodegenerative disorders (Glickman Ciechanover, 2002; Goldberg, 2007; <br />                                              Hershko Ciechanover, 1998). selective degradation intracellular proteins                                              carried ubiquitin-proteasome (UPS) (Finley, 2009; Glickman NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              Ciechanover, 2002; Hershko Ciechanover, 1998; Varshavsky, 2012). Proteins tagged <br />                                              poly-ubiquitin chains hydrolyzed small peptides 26S proteasome                                              energy-dependent manner (Baumeister et al., 1998; Besche et al., 2009b; Demartino                                              Gillette, 2007; Finley, 2009; Tanaka et al., 2012; Tomko Hochstrasser, 2011). <br />  <br />                                              26S proteasome large protease complex composed catalytic 20S subunit                                               known 20S core particle) 19S regulatory particle caps ends                                              20S proteasome (Baumeister et al., 1998; Besche et al., 2009b; Demartino Gillette, <br />                                              2007; Finley, 2009; Lander et al., 2012; Lasker et al., 2012; Murata et al., 2009; Tanaka et <br />                                              al., 2012; Tomko Hochstrasser, 2011). assembly activity 26S proteasome <br />  <br />  <br />                            &#194;&#169; 2013 Elsevier  rights reserved <br />                            * <br />                             Corresponding: author: steller@rockefeller.edu. <br />                            Publisher&apos;s Disclaimer: PDF file unedited manuscript accepted publication. service                            customers providing early version manuscript. manuscript undergo copyediting, typesetting, review                            resulting proof published final citable form. note production process errors                            discovered affect content, legal disclaimers apply journal pertain. <br />                             Cho-Park Steller                                                                                           Page 2 <br />  <br />  <br />                                                   tightly regulated large number loosely associated proteins function                                                   regulators cofactors (Besche et al., 2009b; Finley, 2009; Tanaka et al., 2012; Tomko                                                   Hochstrasser, 2011). factor PI31, evolutionarily conserved regulator NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome activity (Bader et al., 2011; Chu-Ping et al., 1992; McCutchen-Maloney et al., <br />                                                   2000; Zaiss et al., 1999). PI31 initially identified based ability inhibit 20S <br />                                                   proteasome activity vitro (Chu-Ping et al., 1992; McCutchen-Maloney et al., 2000; Zaiss <br />                                                   et al., 1999).  PI31 activate 26S proteasome vitro, mutational <br />                                                   inactivation corresponding gene Drosophila causes lethality, reduced proteasome <br />                                                   activity defects protein degradation vivo (Bader et al., 2011).  PI31 <br />                                                   serves crucial physiological function activator 26S proteasome activity. C- <br />                                                   terminus PI31 contains functionally important HbYX (Hydrophobic residue-Tyrosine- <br />                                                   <span id='am-29' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-30' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-35' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span>) motif, commonly modulators proteasome activity,                                                   Rpt base subunits 19S regulatory particle (Gillette et al., 2008; Rabl et al., 2008; <br />                                                   Smith et al., 2007). suggests PI31 bind 20S particle HbYX-motif, <br />                                                   cause inhibition hindering substrate access enzymatic core (Bader et <br />                                                   al., 2011; McCutchen-Maloney et al., 2000).  precise molecular mechanism                                                   PI31 modulates proteasome activity remains unknown. Previous work indicated <br />                                                   PI31 function regulated vivo increase 26S proteasome activity conditions <br />                                                   maximal proteolytic activity required, example removal cellular <br />                                                   proteins terminal differentiation sperm (Bader et al., 2011). gain                                                   insight regulation PI31 activity looked novel binding partners NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   protein identified ADP-ribosyl transferase tankyrase (TNKS) direct interactor <br />                                                   modulates PI31 activity. TNKS-mediated ADP-ribosylation PI31 necessary                                                   ability protein stimulate 26S proteasome function, inhibition TNKS reduces <br />                                                   26S proteasome activity Drosophila mammalian cells. TNKS-mediated ADP- <br />                                                   ribosylation PI31 drastically reduces affinity protein binding 20S <br />                                                   proteasome &#206;&#177;-subunits relieves 20S repression PI31. identified                                                   19S assembly chaperones dp27 dS5b binding partners PI31. case, ADP- <br />                                                   ribosylation PI31 causes increased binding dp27 dS5b, sequestration                                                   assembly chaperones 19S regulatory particles, promotes 26S assembly.                                                   results reveal novel mechanism proteasome regulation define TNKS-inhibitors                                                   new class proteasome modulators utility clinic. <br />  <br />                               Results <br />                               dTNKS interacts DmPI31 <br />                                                   gain insight mechanism PI31-mediated proteasome regulation, looked                                                   binding partners protein. purpose, screened Drosophila embryo cDNA <br />                                                   library Far-Western analysis using P32-labeled HMK-tagged Drosophila PI31 (DmPI31) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   probe. led identification Drosophila tankyrase (dTNKS, CG4719)                                                   potential interacting protein (data shown). dTNKS protein 44% homologous human <br />                                                   tankyrase 1 2 (hTNKS1/2; Figure S1A).  used IP experiments investigate <br />                                                   endogenous interactions DmPI31 dTNKS (Figure 1B). Extracts wild-type <br />                                                   (WT) embryos immunoprecipitated anti-DmPI31 blots probed                                                   antibody raised dTNKS (Figures 1A S1B). experiments dTNKS <br />                                                   DmPI31 form complex vivo (Figure 1B). expressed FLAG-tagged <br />                                                   dTNKS HA-tagged DmPI31 human 293 cells establish cell culture                                                   subsequent interaction studies (Figure 1C).  IP experiments extracts                                                   cells showed presence DmPI31:dTNKS complex (Figure 1C). <br />  <br />                                                   TNKS belongs poly(ADP-ribose) polymerase (PARP) super-family (D&#226;&#8364;&#8482;Amours et al., <br />                                                   1999; Hsiao Smith, 2008; Smith et al., 1998). TNKSs play diverse roles telomere <br />                                                   maintenance, centrosome maturation, Wnt signaling, embryonic development  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                           Page 3 <br />  <br />  <br />                                                   pathogenesis Cherubism (Guettler et al., 2011; Hsiao Smith, 2008; Huang et al., <br />                                                   2009; Levaot et al., 2011). TNKSs recruit modify target proteins ADP-ribosylation <br />                                                   using Ankyrin (ANK) PARP domains (Figure S1A) (Guettler et al., 2011; Hsiao <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Smith, 2008; Huang et al., 2009; Levaot et al., 2011; Morrone et al., 2012; Smith et al., <br />                                                   1998). Unlike mammals, isoforms TNKS partially redundant function <br />                                                   present, Drosophila genome contains TNKS (Chiang et al., 2008; Chiang et <br />                                                   al., 2006; Hsiao et al., 2006; Hsiao Smith, 2008; Yeh et al., 2009). order identify <br />                                                   region dTNKS responsible interaction DmPI31, generated <br />                                                   truncations dTNKS lack ANK SAM-PARP domains tested                                                   binding DmPI31 (Figures 1D 1E). SAM-PARP domains                                                   dispensable DmPI31-binding, deletion ANK domain dTNKS &#206;&#8221;ANK mutant <br />                                                   prevented formation DmPI31:dTNKS complex (Figure 1E). suggests                                                   dTNKS binds DmPI31 ANK-domain. <br />  <br />                                                   hallmark TNKS-binding partners presence canonical TNKS-binding motif <br />                                                   (RxxGxGxE/D) (Guettler et al., 2011; Hsiao Smith, 2008; Levaot et al., 2011). DmPI31 <br />                                                   contains good fit consensus motif N-terminus (Figure 1F). investigate                                                   functional importance motif, mutated sequence altering amino acids <br />                                                   (RG49/54AA) tested binding dTNKS. mutant protein longer able form <br />                                                   complex dTNKS, indicating motif required interaction dTNKS <br />                                                   (Figure 1G, lane 2). characterize DmPI31-dTNKS interaction, generated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   DmPI31 mutants C-terminal residues, including HbYX motif,                                                   mutated deleted (L210A, D211K, F241A P243A &#206;&#8221;HbYX - Figure 1G; lanes 3&#226;&#8364;&#8220; <br />                                                   7). DmPI31D211K DmPI31P243A mutants retained ability bind dTNKS, <br />                                                   DmPI31L210A DmPI31F241A unable form complex dTNKS (Figure 1G). <br />                                                   Furthermore, deletion HbYX motif DmPI31 abrogated interaction                                                   DmPI31 dTNKS (Figure 1G, lane 7). suggests dTNKS uses ANK-domain <br />                                                   bind DmPI31, N-terminal TNKS-binding motif C-terminal <br />                                                   HbYX domain DmPI31 required interaction dTNKS. <br />  <br />                               dTNKS ADP-ribosylates DmPI31 <br />                                                   TNKSs modulate activity target proteins ADP-ribosylation (Hsiao Smith, <br />                                                   2008; Huang et al., 2009; Smith et al., 1998).  investigated DmPI31                                                   substrate dTNKS-mediated ADP-ribosylation.  used Western blot analysis <br />                                                   monoclonal antibody recognizing poly ADP-ribosylation (PAR)                                                   DmPI31 ADP-ribosylated vivo (Figure 2A, lane 3).  performed vitro <br />                                                   ADP-ribosylation assay incubating Biotin-labeled NAD+ DmPI31                                                   FLAG-dTNKSWT dTNKS &#206;&#8221;PARP recombinant proteins (Figure 2B).                                                   experiments demonstrated dTNKS directly ADP-ribosylate DmPI31 vitro, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   activity requires PARP domain. <br />  <br />                                                   investigated significance TNKS-mediated ADP-ribosylation PI31 function                                                   proteasome regulation, Drosophila subsequently mammalian cells.                                                   purpose, took advantage small molecule inhibitor hTNKS1/2, XAV939 (Huang et <br />                                                   al., 2009). XAV939 discovered screen small molecules affecting Wnt/&#206;&#178;- <br />                                                   catenin signaling pathway (Huang et al., 2009). XAV939 highly specific inhibitor                                                   hTNKS1/2 (Kd = 0.09 &#206;&#188;M) anti-cancer effects APC-deficient colorectal <br />                                                   cancer cells (Huang et al., 2009). tested ability XAV939 inhibit dTNKS                                                   able inhibit auto-ADP-ribosylation activity dTNKS, PARP <br />                                                   (Figures 2C S2A) (Gibson Kraus, 2012; Smith et al., 1998).  XAV939                                                   effective specific TNKS-inhibitor Drosophila. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                            Page 4 <br />  <br />  <br />                               TNKS regulates proteasome activity ADP-ribosylation <br />                                                   DmPI31 required optimal proteasome activity vivo, dTNKS <br />                                                   post-translationally modulate DmPI31, explored possibility inhibition NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   TNKS affects proteasome function.  examined effect TNKS-inhibitor <br />                                                   XAV939 26S proteasome activity Drosophila. Extracts 0&#226;&#8364;&#8220;2h WT embryo                                                   treated different compounds assayed changes proteasome activity (Figure <br />                                                   2E). Treatment XAV939 significantly reduced 26S proteasome activity (Figure 2E). <br />                                                   treatment XAV939 did cause complete inhibition proteasome activity <br />                                                   observed MG312, effect similar inactivation DmPI31 (Bader et al., <br />                                                   2011). results consistent requirement dTNKS DmPI31-mediated <br />                                                   proteasome activation. asked XAV939 inhibit proteasome <br />                                                   activity mammalian cells. purpose, treated 293 cell extracts XAV939                                                   measured 26S proteasome activity (Figure 2F).  exposure                                                   compound decreased proteasome activity. Similar results obtained IWR-1, <br />                                                   TNKS inhibitor structurally unrelated XAV939 (Figure S2B) (Chen et al., <br />                                                   2009; Narwal et al., 2012). supports conclusion observed decrease                                                   proteasome activity caused TNKS inhibition, unrelated target effect                                                   XAV939. corroborate idea, used RNAi target TNKS                                                   Drosophila mammalian cells.  expressed RNAi dTNKS                                                   Drosophila retina background compromised proteasome activity (Figure 3). <br />                                                   Specifically, expression temperature sensitive dominant negative mutant 20S <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome &#206;&#178;2 &#206;&#178;6 subunits causes rough, reduced eye (Belote Fortier, 2002). <br />                                                   Expression RNAi dTNKS enhanced phenotype, similarly                                                   previously observed reduction DmPI31 function (Figures 3C&#226;&#8364;&#8220;E) (Bader et al., 2011). <br />                                                    regulation dTNKS reduces proteasome activity vivo. Finally, used <br />                                                   siRNA knock hTNKS1 hTNKS2 human 293 cells (Figure 2D).                                                    significant reduction 26S proteasome activities observed (Figure 2G). Taken <br />                                                    results TNKS stimulates proteasome activity ADP-ribosylation <br />                                                   PI31. <br />  <br />                               ADP-ribosylation blocks DmPI31 inhibition 20S proteasomes <br />                                                   Best known role DNA damage, ADP-ribosylation transient post-translational <br />                                                   modification drastically alter physical properties target proteins (Chambers et <br />                                                   al., 2012; Gagne et al., 2006; Gibson Kraus, 2012; Wang et al., 2009). order                                                   understand biochemical consequences TNKS-mediated ADP-ribosylation PI31,                                                   investigated modification affects binding properties protein.                                                   mammalian cells, PI31 bind 20S proteasomes (McCutchen-Maloney et al., 2000; <br />                                                   Zaiss et al., 1999). Likewise, DmPI31 bind 20S proteasomes NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Drosophila (Figure 4A). particular, DmPI31 bound selectively &#206;&#177;-subunits: &#206;&#177;1, <br />                                                   &#206;&#177;3, &#206;&#177;4 &#206;&#177;6, &#206;&#177;2 &#206;&#177;5 (Figure 4A).  used immunoprecipitation <br />                                                   experiments evaluate role ADP-ribosylation DmPI31: &#206;&#177; 4-complex. <br />                                                   unmodified PI31 strongly interacted &#206;&#177;4, binding ADP-ribosylated <br />                                                   version significantly diminished (Figure 4B). Consistent observed change                                                   DmPI31 affinity &#206;&#177;-subunits, ADP-ribosylation interfered ability <br />                                                   PI31 inhibit 20S proteasome particles (Figure 4C). results demonstrate                                                   ADP-ribosylation blocks binding DmPI31 20S subunits relieves repression                                                   proteolytic activity protein. <br />  <br />                               dTNKS DmPI31 actively participates proteasome assembly <br />                                                   TNKS-mediated ADP-ribosylation PI31 affects 20S 26S proteasome <br />                                                   activities, investigated possible role TNKS PI31 26S proteasome assembly. <br />                                                    performed Superose 6 gel filtration (FPLC) assays native gel analyses  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                             Page 5 <br />  <br />  <br />                                                   study effect TNKS-inhibitor XAV939 proteasome assembly. Drosophila embryos <br />                                                   ideal study effects 26S assembly ~65% proteasomes exist                                                   20S particles (Nickell et al., 2007). XAV939 treatment Drosophila embryo extracts led NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   significant shift Rpt bands lighter fractions compared controls,                                                   prevented formation 26S proteasomes analyzed native gels (Figures 5A, 5B, <br />                                                   S3A S3B). indicates TNKS activity promotes 26S proteasome assembly. <br />  <br />                                                   examined effect PI31 26S proteasome assembly.  used gel <br />                                                   filtration assays analyze embryo extracts supplemented high concentrations  <br />                                                   DmPI31 recombinant protein (Figure 5C).  addition DmPI31 caused                                                   significant change proteasome architectural landscape redistributing Rpt3 bands <br />                                                   (Figure 5C). observed increase Rpt3 monomers (Figure 5C; panel - <br />                                                   fractions 20&#226;&#8364;&#8220;23). effects seen WT DmPI31, mutant lacking                                                   HbYX motif (Figure 5C). increase Rpt3 monomers explained ability                                                   PI31 bind 19S assembly chaperones   known stabilize assembly <br />                                                   19S regulatory particle 26S proteasome (Funakoshi et al., 2009; Kaneko et al., <br />                                                   2009; Le Tallec et al., 2009; Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009). <br />                                                   Collectively, results TNKS activity PI31 modulate 26S <br />                                                   proteasome assembly, suggest role PI31 promoting 19S stability. <br />  <br />                               19S assembly chaperones interact DmPI31 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   better understand role DmPI31 proteasome assembly, looked additional <br />                                                   DmPI31 binding partners. screen revealed dTNKS DmPI31 interactor, <br />                                                   discovered proteasome-associated proteins, Drosophila p27 (dp27; CG9588) <br />                                                   Drosophila S5b (dS5b; CG12096). p27 S5b play known role 19S assembly <br />                                                   chaperones  Rpn14 Nas6, bind 19S Rpt subunits foster orderly <br />                                                   proteasome assembly (Funakoshi et al., 2009; Kaneko et al., 2009; Le Tallec et al., 2009; <br />                                                   Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009). yeast human,                                                   Drosophila homologs 19S assembly chaperones (dp27: 41% dS5b: 23.3% <br />                                                   homologous; Figures 6B S5A) essential genes required organismal viability <br />                                                   (Figures 3F&#226;&#8364;&#8220;L, S4A S4B). IP experiments anti-DmPI31 using Drosophila embryo <br />                                                   extracts followed Western analysis using anti-dp27 reveal DmPI31 binds dp27                                                   vivo (Figures 6A S4C). identify DmPI31 residues involved dp27 dS5b <br />                                                   binding, used point mutants previously employed map DmPI31:dTNKS <br />                                                   interaction (Figure 1G). mutants defective TNKS-binding (RG49/54AA) failed                                                   destabilize DmPI31:assembly chaperone complex, mutating conserved C-terminus                                                   DmPI31 (L210, F241 HbYX motif) disrupted interactions (Figures 6C S5B). <br />                                                   results C-terminal HbYX motif required formation                                                   complex DmPI31 assembly chaperones dp27 dS5b. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Despite structural differences, 19S assembly chaperones use common mechanism                                                   bind 19S Rpt subunits (Barrault et al., 2012; Funakoshi et al., 2009; Lee et al., 2011; Park <br />                                                   et al., 2009; Roelofs et al., 2009; Saeki et al., 2009; Takagi et al., 2012). dp27                                                   dS5b interact DmPI31 C-terminus, performed protein sequence alignments <br />                                                   dp27, dS5b dRpn14. identified putative DmPI31-binding motifs  III; <br />                                                   Figure 6D). order test functional relevance motifs, mutated sites <br />                                                   examined consequences DmPI31 interaction (Figures 6E S5C). Point <br />                                                   mutations replaced key residues motifs III dp27 dS5b (dp27: E9A                                                   R187A; dS5b: E44A R263A) failed recruit DmPI31, indicating requirement                                                   motifs interaction DmPI31 (Figures 6E S5C). results suggest                                                   dp27 dS5b novel interacting partners DmPI31. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                               Page 6 <br />  <br />  <br />                               ADP-ribosylation promotes 26S proteasome assembly increasing affinity DmPI31 <br />                               assembly chaperones <br />                                                   ADP-ribosylation PI31 modulates 20S proteasome activity altering affinity NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   &#206;&#177;-subunits (Figure 4), wondered post-translational modification affect <br />                                                   interaction 19S assembly chaperones p27 S5b. examine possibility,                                                   performed anti-FLAG IP experiment using 293 cell extracts standardized FLAG- <br />                                                   dp27 HA-dRpt5 expression, followed rigorous washing addition                                                   incremental amounts vitro modified DmPI31. effects ADP-ribosylated DmPI31 <br />                                                   stability dp27:dRpt5 dS5b:dRpt2 complexes visualized Western blot <br />                                                   (Figures 7A S6A). Countering effect &#206;&#177;4 subunit, compared                                                   unmodified version, ADP-ribosylation considerably increased ability DmPI31                                                   recruit assembly chaperones, sequestering away Rpt base subunits                                                   dose-dependent manner (compare Figures 7A S6A Figures 7B S6B, <br />                                                   respectively). results, presented earlier indicate ADP- <br />                                                   ribosylation directly modifies DmPI31 affinity proteasome-associated proteins. <br />  <br />                                                   Evidence role PI31 activator 26S proteasome previously based                                                   requirement protein normal proteasome activity vivo, ability                                                   protein stimulate 26S proteasome activity vitro (Bader et al., 2011). modification <br />                                                   ADP-ribosylation differentially affects interaction DmPI31 different proteasome <br />                                                   proteins, investigated consequences PI31-modification 26S proteasome activity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   vitro. ADP-ribosylated DmPI31 significantly potent stimulating                                                   chymotrypsin-like activity purified 26S proteasomes vitro (Figure 7C). Furthermore, <br />                                                   modified DmPI31 incubated purified 20S 19S particles analyzed                                                   native gels, saw ADP-ribosylation increased ability DmPI31 promote                                                   novo 26S assembly vitro (Figure 7D). Finally, addition ADP-ribosylated DmPI31 <br />                                                   extracts pre-treated XAV939 reversed inhibitory effect compound 26S <br />                                                   proteasome assembly able increase 26S proteasome assembly <br />                                                   (Figure 7E). surplus PI31 overcome effects XAV939, albeit <br />                                                   efficiently modified counterpart. consistent observation                                                   unmodified PI31 bind sequester 19S assembly chaperones (Figure S6B). Taken <br />                                                    data dTNKS-dependent ADP-ribosylation DmPI31 stimulates 26S <br />                                                   proteasome activity promoting 26S assembly. <br />  <br />                               Discussion <br />                                                   increasingly clear proteasome, thought constitutively <br />                                                   active protease complex, dynamically regulated meet changing proteolytic needs                                                   cell (Demartino Gillette, 2007; Glickman Ciechanover, 2002; Hershko NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Ciechanover, 1998). poly-ubiquitination substrates central select specific <br />                                                   proteins degradation, additional mechanisms exist account plasticity                                                   proteasome activity (Crosas et al., 2006; Demartino Gillette, 2007; Hanna et al., 2007; <br />                                                   Kurucz et al., 2002; Murata et al., 2009; Peth et al., 2009; Peth et al., 2013; Peth et al., 2010; <br />                                                   Princiotta et al., 2001).  identified TNKS novel regulator proteasome <br />                                                   activity Drosophila mammalian cells. Specifically, TNKS- <br />                                                   mediated ADP-ribosylation PI31 alters affinity protein 20S proteasome &#206;&#177;- <br />                                                   subunits 19S assembly chaperones stimulates 26S proteasome assembly. <br />                                                   results support model TNKS activates evolutionarily conserved <br />                                                   proteasome regulatory protein, PI31, ADP-ribosylation (Figure 7F). PI31                                                   physiologically required optimal 26S proteasome activity vivo, inactivation                                                   corresponding gene Drosophila causes reduced protein breakdown organismal <br />                                                   lethality (Bader et al., 2011). Inhibition TNKS RNAi specific small- <br />                                                   molecule inhibitor, XAV939, blocked ADP-ribosylation PI31 impaired 26S <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                              Page 7 <br />  <br />  <br />                                                   proteasome activity similar inactivation PI31. suggested PI31 act                                                   modulator proteasome assembly reversibly associating 20S proteasome (Besche <br />                                                   et al., 2009a; McCutchen-Maloney et al., 2000; Tai et al., 2010; Tanahashi et al., 1999; Zaiss <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   et al., 1999; Zaiss et al., 2002). support idea, PI31 modification                                                   TNKS facilitates assembly 26S proteasome acting crucial stages (Figure <br />                                                   7F).  TNKS-mediated ADP-ribosylation decreases affinity PI31 &#206;&#177;4 subunits <br />                                                   20S particle. dislodges PI31 20S proteasomes prevents PI31                                                   inhibiting 20S activity. free, modified PI31 competes Rpt subunits sequester <br />                                                   assembly chaperones p27 S5b away 19S regulatory particles,                                                   promoting capping 20S 19S particles. consistent previous <br />                                                   observations overexpression p27, S5b Rpn14/PAAF1 proteins negatively <br />                                                   affected proteasome assembly (Kaneko et al., 2009; Lassot et al., 2007; Park et al., 2005; <br />                                                   Shim et al., 2012). acting 20S particles assembly chaperones, PI31 appears <br />                                                   function central regulator 26S proteasome assembly (Figure 7F). Significantly,                                                   process disrupted existing small-molecule compounds: TNKS-inhibitors <br />                                                   represent novel class compounds inhibit 26S activity interfering                                                   proteasome assembly. <br />  <br />                                                   PI31 required normal proteasome activity vivo, stimulate activity <br />                                                   purified 26S proteasome vitro (Bader et al., 2011). order explain finding, <br />                                                   invoke possibility purified 26S proteasomes used experiments contain <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   associated proteins, including 19S assembly chaperones. consistent observations <br />                                                   showing p27 S5b association purified 26S proteasome (Besche et al., 2009a; <br />                                                   Deveraux et al., 1995; Gomes et al., 2006; Tai et al., 2010; Watanabe et al., 1998). <br />                                                   Furthermore, unmodified PI31 bind assembly chaperones, albeit lower <br />                                                   efficiency (Figure S6B). Taken  results suggest PI31 stimulates <br />                                                   proteasome activity vitro increasing 26S particles. <br />  <br />                                                   rate intracellular protein degradation dramatically affected various signals, <br />                                                   including metabolic state cell (Glickman Ciechanover, 2002). example, <br />                                                   caloric restriction cause severe reduction skeletal muscles, humans loose large <br />                                                   fraction muscle mass aging. appears evolved                                                   protective mechanism cope food shortage, muscle atrophy highly <br />                                                   debilitating process occurs various diseases, cancer cachexia, AIDS, <br />                                                   renal failure, neuro-degenerative diseases. cases, proteasome activity                                                   responsible protein breakdown cellular atrophy, direct connection                                                   metabolism proteasome activity established. NAD+ source <br />                                                   ADP-ribose group, proteasome regulation TNKS provides potential new link <br />                                                   cell metabolism regulation protein degradation (Gibson Kraus, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   2012). ADP-ribosylation short half-life (1&#226;&#8364;&#8220;2 min), ideally suited                                                   rapidly signal transient changes cell physiology (Chambers et al., 2012; Gibson                                                   Kraus, 2012; Lindahl et al., 1995; Wang et al., 2009). speculate TNKS-mediated <br />                                                   activation PI31 serve stimulate proteasome activity cells need                                                   dynamically boost proteolytic capacity meet changing demands,                                                   cellular remodeling, stress caloric restriction. possible                                                   activation PI31 occurs specific subcellular compartments, example                                                   nucleus, specific neuronal processes undergoing pruning, synapses                                                   remodeling. way, possible locally fine-tune assembly activity                                                   26S proteasomes meet cell&#226;&#8364;&#8482;s changing needs controlled proteolysis. <br />  <br />                                                   proteasome validated drug target cancer therapy bortezomib (&#226;&#8364;&#339;Velcade&#226;&#8364;?), <br />                                                   inhibits chymotrypsin-like activity proteasome, approved                                                   treatment multiple myeloma mantle cell lymphoma (Goldberg, 2012; Kisselev et <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                          Page 8 <br />  <br />  <br />                                                   al., 2012; Raab et al., 2009). Problems associated bortezomib include notable                                                   effects, peripheral neuropathy drug resistance (Goldberg, 2012; Kisselev et al., <br />                                                   2012; Raab et al., 2009).  drugs inhibit proteasome activity separate <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   mechanism considerable clinical value. findings suggest TNKS- <br />                                                   inhibitors, XAV939 IWR-1, useful treatment multiple <br />                                                   myeloma, mantle cell lymphoma cancers sensitive proteasome inhibition. <br />                                                   Consistent idea, preliminary evidence XAV939 block growth <br />                                                   multiple myeloma cells (Figure S6C). inhibiting proteasome activity                                                   entirely distinct mechanism, TNKS-inhibitors expected block maximal activation <br />                                                   26S function, basal activity proteasome fewer                                                   effects (Figure 7F). Interestingly, XAV939 shown effective                                                   colorectal cancer cells thought antagonize Wnt-signaling preventing                                                   degradation axin (Huang et al., 2009).  contribution proteasome inhibition <br />                                                   paradigm determined. Proteasome regulation tankyrase-mediated <br />                                                   ADP-ribosylation provides unexpected new mechanism regulate protein degradation <br />                                                   targeted small-molecule inhibitors. <br />  <br />                               Experimental Procedures <br />                               Recombinant Protein Purification Far-Western screening cDNA library <br />                                                   purification DmPI31, DmPI31&#206;&#8221;HbYX, HMK-DmPI31  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   dTNKS&#206;&#8221;PARP fusion proteins, E.coli BL21 (Invitrogen) transformed pET28- <br />                                                   DmPI31, pET28 DmPI31&#206;&#8221;HbYX, pET101 HMK-DmPI31 pET101  <br />                                                   dTNKS&#206;&#8221;PARP constructs. Following 2h induction 37&#194;&#176;C 0.1 mM IPTG, fusion <br />                                                   proteins purified TALON&#226;&#8222;&#162; Metal Affinity resin (BD Bioscience) according                                                   manufacturer&#226;&#8364;&#8482;s instructions. purification FLAG-dTNKS FLAG-dPARP, <br />                                                   HEK293 cell extracts expressing pcDNA3.2-FLAG-dTNKS pcDNA3.2-FLAG- <br />                                                   dPARP constructs incubated anti- FLAG&#194;&#174;M2-Affinity Gel (Sigma) 3h                                                   purified using FLAG&#194;&#174; <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span>peptide</span> (Sigma) according manufacturer&#226;&#8364;&#8482;s instructions. Far- <br />                                                   Western screening cDNA library performed previous described (Pause et al., <br />                                                   1994) using Drosophila &#206;&#187; cDNA library (Stratagene). <br />  <br />                               Cell Culture/Growth assay <br />                                                   Cationic <span id='am-12' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-13' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-14' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="lipid" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span>lipid</span> reagent (20 &#206;&#188;l Lipofectamine 2000; Invitrogen) diluted serum free <br />                                                   media (Opti-MEM; Invitrogen) transfection Human Embryonic Kidney 293 cells <br />                                                   (100mm dish). Following 5h incubation, medium replaced Dulbecco&#226;&#8364;&#8482;s <br />                                                   Modified Eagle Medium(DMEM; Invitrogen) supplemented 10% Fetal Bovine Serum <br />                                                   (FBS). Transfected cells harvested PBS 48h following addition serum <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   containing media. cells lysed repeated freeze/thaw cycles 600 &#206;&#188;l                                                   lysis buffer (20mM Hepes-KOH, pH 7.6, 200mM KCl, 0.5mM EDTA, 10% glycerol, 1% <br />                                                   Triton X-100 Protease Inhibitor Cocktail (Complete&#226;&#8222;&#162;; Roche)) contains RNAse                                                   (50 &#206;&#188;g/ml; Sigma). Cell debris pelleted centrifugation, protein concentration <br />                                                   supernatant determined using Bio-Rad assay. siRNAs purchased                                                   Invitrogen (sequences shown Table S1) transfected 293 cells final <br />                                                   concentration 50nM/100mm dishes using Lipofectamine 2000. Effects drug treatment <br />                                                   U266 multiple myeloma cell growth performed using 0.1 &#206;&#188;M bortezomib 5 <br />                                                   &#206;&#188;M XAV939 low FBS (0.5%) RPMI media, 96 plates seeded ~8000 <br />                                                   cells  Samples assayed growth/viability using PrestoBlue&#194;&#174; Cell Viability <br />                                                   Reagent (Invitrogen) Spectramax M2 reader (Molecular Devices) manufacturer&#226;&#8364;&#8482;s <br />                                                   instructions. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                         Page 9 <br />  <br />  <br />                               Immunoprecipitation <br />                                                   immunoprecipitation, 293 cell extract (200 &#206;&#188;l; 6&#226;&#8364;&#8220;10 &#206;&#188;g/ &#206;&#188;l) brought 1ml <br />                                                   lysis buffer pre-cleared 1h 4&#194;&#176;C 25 &#206;&#188;l Protein Sepharose (GE <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Healthcare). supernatant immunoprecipitated 1h 4&#194;&#176;C 25 &#206;&#188;l anti- <br />                                                   FLAG&#194;&#174;M2-Affinity Gel (Sigma). resin washed twice lysis buffer                                                   lysis buffer containing 300mM KCl. Immunoprecipitates eluted 3X red sample <br />                                                   buffer (NEB). anti-HA anti-DmPI31 immunoprecipitations, 25 &#206;&#188;l Protein                                                   Sepharose pre-incubated 2h anti-HA (3 &#206;&#188;l) anti-DmPI31 (5 &#206;&#188;l).                                                   resins washed times lysis buffer prior immunoprecipitation                                                   described  Embryo extracts used concentration 5 &#206;&#188;g/ &#206;&#188;l. <br />  <br />                               Proteasome activity Assay <br />                                                   50 &#206;&#188;g 0&#226;&#8364;&#8220;2h WT (yw) embryo 3 &#206;&#188;g 293 cell extracts PIPES buffer (50mM PIPES, <br />                                                   1mMMgCl2, 50mM NaCl, 2mM EGTA 2mM <span id='am-18' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-19' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span>ATP</span>) programmed 1% DMSO <br />                                                   (Sigma), 5 &#206;&#188;M MG132 (Calbiochem), 2 &#206;&#188;M XAV939 (Sigma) 2 &#206;&#188;M IWR-1 (Sigma), <br />                                                   respectively, incubated 20 min room temperature. Samples assayed                                                   proteasome activity using Proteasome-Glo&#226;&#8222;&#162; Chymotrypsin-like Cell-Based assay <br />                                                   (Promega) Spectramax M2 reader (Molecular Devices). assess effect ADP- <br />                                                   ribosylation 20S 26S proteasome activities purified bovine 20S 26S <br />                                                   proteasomes (0.1 &#206;&#188;g; UBPBio) PIPES buffer + 2mM ATP programmed 2 &#206;&#188;g <br />                                                   DmPI31WT, DmPI31&#206;&#8221;HbYX DmPI31ADPR, incubated 20 min NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   room temperature. Samples assayed proteasome activity described  <br />  <br />                               Gel Filtration assay <br />                                                   2mg 0&#226;&#8364;&#8220;2h WT embryo extracts prepared using PIPES buffer + 2mM ATP                                                   centrifuged twice 14 000 rpm 20 min 4&#194;&#176;C prior treated 50 &#206;&#188;g  <br />                                                   DmPI31, 50 &#206;&#188;g DmPI31&#206;&#8221;HbYX, 50 &#206;&#188;g DmPI31ADP-ribosylation, 1% DMSO, 5 &#206;&#188;M <br />                                                   MG132, 2&#206;&#188;M XAV939 2 &#206;&#188;M Olaparib (LC laboratories) 30 min. Gel filtration <br />                                                   assay subsequently performed using Superose 6 10/300GL FPLC column (AKTA; GE <br />                                                   Healthcare). 500 &#206;&#188;l fractions collected using 0.250 ml/min flow rate. Purified bovine <br />                                                   19S, 20S 26S proteasomes (UBPBio), thyroglobulin, BSA used standards. <br />  <br />                               vitro ADP-ribosylation Assay Purification DmPI31ADPR <br />                                                   Recombinant DmPI31 (1 &#206;&#188;g), FLAG-dTNKS (0.1 &#206;&#188;g) dTNKS&#206;&#8221;PARP (0.1 &#206;&#188;g), <br />                                                   biotin-NAD+ (3.5 &#206;&#188;M; Trevigen) incubated 5h 37&#194;&#176;C subjected <br />                                                   SDS-PAGE followed Western Blotting using Streptavidin-HRP (Thermo-Scientific; <br />                                                   1:10000). Effect XAV939 dTNKS dPARP assessed incubating FLAG- <br />                                                   dTNKS FLAG-dPARP/Biotin-NAD+ mixture 0.1% DMSO 0.1 &#206;&#188;M <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   XAV939. purification DmPI31ADPR protein, vitro ADP-ribosylation                                                   recombinant DmPI31 protein performed  followed serial <br />                                                   purifications using TALON Metal Affinity resin (ClonTech) SoftLink&#226;&#8222;&#162; Soft Release <br />                                                   Avidin resin (Promega) manufactures&#226;&#8364;&#8482; instructions. <br />  <br />                               Native Gel analysis <br />                                                   analyze proteasome assembly status, 200 &#206;&#188;g embryo extracts exposed different <br />                                                   experimental conditions + 2mM ATP resolved using 5% Tris-HCl acrylamide gels <br />                                                   (Bio-rad) non-denaturing conditions transferred 0.22 &#206;&#188;m PVDF <br />                                                   membrane. Western blot analysis using specific antibodies performed described <br />                                                    Concentrations various reagents  1% DMSO, 5 &#206;&#188;M MG132, 2 &#206;&#188;M XAV939, <br />                                                   purified bovine 19S 20S (1 &#206;&#188;g), 5&#206;&#188;g DmPI31WT, DmPI31&#206;&#8221;HbYX                                                   DmPI31ADPR proteins. <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                              Page 10 <br />  <br />  <br />                               Fly Strains <br />                                                   UAS-DTS5 UAS-DTS7 lines obtained J. Belote, dTNKS (21930, 21932                                                   106238), dp27 (28527, 47762 47763), dS5b (104492) dRpn14 (32697 32698) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   RNAi lines obtained Vienna Drosophila RNAi Center (VDRC)                                                   Bloomington Drosophila Stock Center. <br />  <br />                               Supplementary Material <br />                                                   Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                                   alphabetical order, thank J. Belote providing fly strains; G. DeMartino,  Goldberg S. Larisch                                                   critical comments manuscript; S. Benjamin-Hong, O. Cho, B. Cho-Park, Y  Cho-Park, D. Ferres-Marco, <br />                                                   N. Gandagar, T. Hsiao,  Kelkar, L  Park, C. Pham, J. Rodriguez,  Sachrai, C. Sandu members lab <br />                                                   valuable discussions; J. Gee-Esposito, T. Gorenc, O. Matthew  Persaud logistical support. H.S.                                                   Investigator Howard Hughes Medical Institute. work supported NIH grant RO1GM60124                                                   H.S. <br />  <br />  <br />                               References <br />                                                   Bader M, Benjamin S, Wapinski OL, Smith DM, Goldberg AL, Steller H. conserved F box <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     regulatory complex controls proteasome activity Drosophila. Cell. 2011; 145:371&#226;&#8364;&#8220;382. [PubMed: <br />                                                     21529711] <br />                                                   Barrault MB, Richet N, Godard C, Murciano B, Le Tallec B, Rousseau E, Legrand P, Charbonnier JB, <br />                                                     Le Du MH, Guerois R, et al. Dual functions Hsm3 protein chaperoning scaffolding <br />                                                     regulatory particle subunits proteasome assembly. Proc Natl Acad Sci U S  2012; <br />                                                     109:E1001&#226;&#8364;&#8220;1010. [PubMed: 22460800] <br />                                                   Baumeister W, Walz J, Zuhl F, Seemuller E. proteasome: paradigm self-compartmentalizing <br />                                                     protease. Cell. 1998; 92:367&#226;&#8364;&#8220;380. [PubMed: 9476896] <br />                                                   Belote JM, Fortier E. Targeted expression dominant negative proteasome mutants Drosophila <br />                                                     melanogaster. Genesis. 2002; 34:80&#226;&#8364;&#8220;82. [PubMed: 12324954] <br />                                                   Besche HC, Haas W, Gygi SP, Goldberg AL. Isolation mammalian 26S proteasomes p97/VCP <br />                                                     complexes using ubiquitin-like domain HHR23B reveals novel proteasome-associated <br />                                                     proteins. Biochemistry. 2009a; 48:2538&#226;&#8364;&#8220;2549. [PubMed: 19182904] <br />                                                   Besche HC, Peth  Goldberg AL. Getting base proteasome assembly. Cell. 2009b; 138:25&#226;&#8364;&#8220; <br />                                                     28. [PubMed: 19596233] <br />                                                   Chambers JE, Petrova K, Tomba G, Vendruscolo M, Ron D. ADP ribosylation adapts ER <br />                                                     chaperone response short-term fluctuations unfolded protein load. J Cell Biol. 2012; 198:371&#226;&#8364;&#8220; <br />                                                     385. [PubMed: 22869598] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Chen B, Dodge  Tang W, Lu J, Ma  Fan CW, Wei S, Hao W, Kilgore J, Williams NS, et al. <br />                                                     Small molecule-mediated disruption Wnt-dependent signaling tissue regeneration cancer. <br />                                                     Nat Chem Biol. 2009; 5:100&#226;&#8364;&#8220;107. [PubMed: 19125156] <br />                                                   Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, Smith S, Hodes RJ. Tankyrase 1                                                     tankyrase 2 essential redundant mouse embryonic development. PLoS  2008; <br />                                                     3:e2639. [PubMed: 18612384] <br />                                                   Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ. Generation <br />                                                       characterization telomere length maintenance tankyrase 2-deficient mice. Mol Cell Biol. <br />                                                       2006; 26:2037&#226;&#8364;&#8220;2043. [PubMed: 16507984] <br />                                                   Chu-Ping M, Slaughter CA, DeMartino GN. Purification characterization protein inhibitor                                                       20S proteasome (macropain). Biochim Biophys Acta. 1992; 1119:303&#226;&#8364;&#8220;311. [PubMed: <br />                                                       1312359] <br />                                                   Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, Buecker C, Leggett DS, <br />                                                       Schmidt M, King RW, et al. Ubiquitin chains remodeled proteasome opposing <br />                                                       ubiquitin ligase deubiquitinating activities. Cell. 2006; 127:1401&#226;&#8364;&#8220;1413. [PubMed: 17190603] <br />  <br />  <br />                                                            Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                   Page 11 <br />  <br />  <br />                                                   D&#226;&#8364;&#8482;Amours D, Desnoyers S, D&#226;&#8364;&#8482;Silva  Poirier GG. Poly(ADP-ribosyl)ation reactions regulation <br />                                                       nuclear functions. Biochem J. 1999; 342(Pt 2):249&#226;&#8364;&#8220;268. [PubMed: 10455009] <br />                                                   Demartino GN, Gillette TG. Proteasomes: machines reasons. Cell. 2007; 129:659&#226;&#8364;&#8220;662. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       [PubMed: 17512401] <br />                                                   Deveraux Q, Jensen C, Rechsteiner M. Molecular cloning expression 26 S protease subunit <br />                                                       enriched dileucine repeats. J Biol Chem. 1995; 270:23726&#226;&#8364;&#8220;23729. [PubMed: 7559544] <br />                                                   Finley D. Recognition processing ubiquitin-protein conjugates proteasome. Annu Rev <br />                                                       Biochem. 2009; 78:477&#226;&#8364;&#8220;513. [PubMed: 19489727] <br />                                                   Funakoshi M, Tomko RJ Jr, Kobayashi H, Hochstrasser M. Multiple assembly chaperones govern <br />                                                       biogenesis proteasome regulatory particle base. Cell. 2009; 137:887&#226;&#8364;&#8220;899. [PubMed: <br />                                                       19446322] <br />                                                   Gagne JP, Hendzel MJ, Droit  Poirier GG. expanding role poly(ADP-ribose) metabolism: <br />                                                       current challenges new perspectives. Curr Opin Cell Biol. 2006; 18:145&#226;&#8364;&#8220;151. [PubMed: <br />                                                       16516457] <br />                                                   Gibson BA, Kraus WL. New insights molecular cellular functions poly(ADP-ribose) <br />                                                       PARPs. Nat Rev Mol Cell Biol. 2012; 13:411&#226;&#8364;&#8220;424. [PubMed: 22713970] <br />                                                   Gillette TG, Kumar B, Thompson D, Slaughter CA, DeMartino GN. Differential roles COOH <br />                                                       termini AAA subunits PA700 (19 S regulator) asymmetric assembly activation                                                       26 S proteasome. J Biol Chem. 2008; 283:31813&#226;&#8364;&#8220;31822. [PubMed: 18796432] <br />                                                   Glickman MH, Ciechanover  ubiquitin-proteasome proteolytic pathway: destruction sake <br />                                                       construction. Physiol Rev. 2002; 82:373&#226;&#8364;&#8220;428. [PubMed: 11917093] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Goldberg AL. prions, proteasomes, mad cows. N Engl J Med. 2007; 357:1150&#226;&#8364;&#8220;1152. <br />                                                       [PubMed: 17855677] <br />                                                   Goldberg AL. Development proteasome inhibitors research tools cancer drugs. J Cell Biol. <br />                                                       2012; 199:583&#226;&#8364;&#8220;588. [PubMed: 23148232] <br />                                                   Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, <br />                                                       Qiao X, et al. Mapping murine cardiac 26S proteasome complexes. Circ Res. 2006; 99:362&#226;&#8364;&#8220; <br />                                                       371. [PubMed: 16857966] <br />                                                   Guettler S, LaRose J, Petsalaki E, Gish G, Scotter  Pawson T, Rottapel R, Sicheri F. Structural basis <br />                                                       sequence rules substrate recognition Tankyrase explain basis cherubism disease. <br />                                                       Cell. 2011; 147:1340&#226;&#8364;&#8220;1354. [PubMed: 22153077] <br />                                                   Hanna J, Meides  Zhang DP, Finley D. ubiquitin stress response induces altered proteasome <br />                                                       composition. Cell. 2007; 129:747&#226;&#8364;&#8220;759. [PubMed: 17512408] <br />                                                   Hershko  ubiquitin protein degradation roles control cell <br />                                                       division cycle. Cell Death Differ. 2005; 12:1191&#226;&#8364;&#8220;1197. [PubMed: 16094395] <br />                                                   Hershko  Ciechanover  ubiquitin  Annu Rev Biochem. 1998; 67:425&#226;&#8364;&#8220;479. [PubMed: <br />                                                       9759494] <br />                                                   Hsiao SJ, Poitras MF, Cook BD, Liu Y, Smith S. Tankyrase 2 poly(ADP-ribose) polymerase domain- <br />                                                       deleted mice exhibit growth defects normal telomere length capping. Mol Cell Biol. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       2006; 26:2044&#226;&#8364;&#8220;2054. [PubMed: 16507985] <br />                                                   Hsiao SJ, Smith S. Tankyrase function telomeres, spindle poles,  Biochimie. 2008; <br />                                                       90:83&#226;&#8364;&#8220;92. [PubMed: 17825467] <br />                                                   Huang SM, Mishina YM, Liu S, Cheung  Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang <br />                                                       Y, Wiessner S, et al. Tankyrase inhibition stabilizes axin antagonizes Wnt signalling. Nature. <br />                                                       2009; 461:614&#226;&#8364;&#8220;620. [PubMed: 19759537] <br />                                                   Kaneko T, Hamazaki J, Iemura S, Sasaki K, Furuyama K, Natsume T, Tanaka K, Murata S. Assembly <br />                                                       pathway Mammalian proteasome base subcomplex mediated multiple specific <br />                                                       chaperones. Cell. 2009; 137:914&#226;&#8364;&#8220;925. [PubMed: 19490896] <br />                                                   Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: expanding army attacking <br />                                                       unique target. Chem Biol. 2012; 19:99&#226;&#8364;&#8220;115. [PubMed: 22284358] <br />                                                   Kurucz E, Ando  Sumegi M, Holzl H, Kapelari B, Baumeister W, Udvardy  Assembly                                                       Drosophila 26 S proteasome accompanied extensive subunit rearrangements. Biochem J. <br />                                                       2002; 365:527&#226;&#8364;&#8220;536. [PubMed: 11945175] <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                  Page 12 <br />  <br />  <br />                                                   Lander GC, Estrin E, Matyskiela  Bashore C, Nogales E, Martin  Complete subunit architecture <br />                                                       proteasome regulatory particle. Nature. 2012; 482:186&#226;&#8364;&#8220;191. [PubMed: 22237024] <br />                                                   Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, Unverdorben P, Beck F, Aebersold R, Sali  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       Baumeister W. Molecular architecture 26S proteasome holocomplex determined                                                       integrative approach. Proc Natl Acad Sci U S  2012; 109:1380&#226;&#8364;&#8220;1387. [PubMed: 22307589] <br />                                                   Lassot  Latreille D, Rousset E, Sourisseau M, Linares LK, Chable-Bessia C, Coux O, Benkirane M, <br />                                                       Kiernan  proteasome regulates HIV-1 transcription proteolytic nonproteolytic <br />                                                       mechanisms. Mol Cell. 2007; 25:369&#226;&#8364;&#8220;383. [PubMed: 17289585] <br />                                                   Le Tallec B, Barrault MB, Guerois R, Carre T, Peyroche  Hsm3/S5b participates assembly <br />                                                       pathway 19S regulatory particle proteasome. Mol Cell. 2009; 33:389&#226;&#8364;&#8220;399. [PubMed: <br />                                                       19217412] <br />                                                   Lee SY, la Mota-Peynado  Roelofs J. Loss Rpt5 protein interactions core particle                                                       Nas2 protein causes formation faulty proteasomes inhibited Ecm29 protein. J <br />                                                       Biol Chem. 2011; 286:36641&#226;&#8364;&#8220;36651. [PubMed: 21878651] <br />                                                   Levaot N, Voytyuk O, Dimitriou  Sircoulomb F, Chandrakumar  Deckert M, Krzyzanowski PM, <br />                                                       Scotter  Gu S, Janmohamed S, et al. Loss Tankyrase-mediated destruction 3BP2                                                       underlying pathogenic mechanism cherubism. Cell. 2011; 147:1324&#226;&#8364;&#8220;1339. [PubMed: <br />                                                       22153076] <br />                                                   Lindahl T, Satoh MS, Poirier GG, Klungland  Post-translational modification poly(ADP-ribose) <br />                                                       polymerase induced DNA strand breaks. Trends Biochem Sci. 1995; 20:405&#226;&#8364;&#8220;411. [PubMed: <br />                                                       8533153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   McCutchen-Maloney SL, Matsuda K, Shimbara N, Binns DD, Tanaka K, Slaughter CA, DeMartino <br />                                                       GN. cDNA cloning, expression, functional characterization PI31, proline-rich inhibitor                                                       proteasome. J Biol Chem. 2000; 275:18557&#226;&#8364;&#8220;18565. [PubMed: 10764772] <br />                                                   Morrone S, Cheng  Moon RT, Cong F, Xu W. Crystal structure Tankyrase-Axin complex                                                       implications Axin turnover Tankyrase substrate recruitment. Proc Natl Acad Sci U S  <br />                                                       2012; 109:1500&#226;&#8364;&#8220;1505. [PubMed: 22307604] <br />                                                   Murata S, Yashiroda H, Tanaka K. Molecular mechanisms proteasome assembly. Nat Rev Mol Cell <br />                                                       Biol. 2009; 10:104&#226;&#8364;&#8220;115. [PubMed: 19165213] <br />                                                   Narwal M, Venkannagari H, Lehtio L. Structural basis selective inhibition human tankyrases. J <br />                                                       Med Chem. 2012; 55:1360&#226;&#8364;&#8220;1367. [PubMed: 22233320] <br />                                                   Nickell S, Mihalache O, Beck F, Hegerl R, Korinek  Baumeister W. Structural analysis 26S <br />                                                       proteasome cryoelectron tomography. Biochem Biophys Res Commun. 2007; 353:115&#226;&#8364;&#8220;120. <br />                                                       [PubMed: 17173858] <br />                                                   Park S, Roelofs J, Kim W, Robert J, Schmidt M, Gygi SP, Finley D. Hexameric assembly                                                       proteasomal ATPases templated C termini. Nature. 2009; 459:866&#226;&#8364;&#8220;870. [PubMed: <br />                                                       19412160] <br />                                                   Park Y, Hwang YP, Lee JS, Seo SH, Yoon SK, Yoon JB. Proteasomal ATPase-associated factor 1 <br />                                                       negatively regulates proteasome activity interacting proteasomal ATPases. Mol Cell Biol. <br />                                                       2005; 25:3842&#226;&#8364;&#8220;3853. [PubMed: 15831487] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Pause  Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N. Insulin- <br />                                                       dependent stimulation protein synthesis phosphorylation regulator 5&#226;&#8364;&#178;-cap function. <br />                                                       Nature. 1994; 371:762&#226;&#8364;&#8220;767. [PubMed: 7935836] <br />                                                   Peth  Besche HC, Goldberg AL. Ubiquitinated proteins activate proteasome binding                                                       Usp14/Ubp6, causes 20S gate opening. Mol Cell. 2009; 36:794&#226;&#8364;&#8220;804. [PubMed: 20005843] <br />                                                   Peth  Kukushkin N, Bosse M, Goldberg AL. Ubiquitinated proteins activate proteasomal <br />                                                       ATPases binding Usp14 Uch37. J Biol Chem. 2013 <br />                                                   Peth  Uchiki T, Goldberg AL. ATP-dependent steps binding ubiquitin conjugates                                                       26S proteasome commit degradation. Mol Cell. 2010; 40:671&#226;&#8364;&#8220;681. [PubMed: 21095592] <br />                                                   Princiotta MF, Schubert U, Chen W, Bennink JR, Myung J, Crews CM, Yewdell JW. Cells adapted                                                       proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone <br />                                                       require enzymatically active proteasomes continued survival. Proc Natl Acad Sci U S  2001; <br />                                                       98:513&#226;&#8364;&#8220;518. [PubMed: 11149939] <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                Page 13 <br />  <br />  <br />                                                   Raab MS, Podar K, Breitkreutz  Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009; <br />                                                       374:324&#226;&#8364;&#8220;339. [PubMed: 19541364] <br />                                                   Rabl J, Smith DM, Yu Y, Chang SC, Goldberg AL, Cheng Y. Mechanism gate opening 20S <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       proteasome proteasomal ATPases. Mol Cell. 2008; 30:360&#226;&#8364;&#8220;368. [PubMed: 18471981] <br />                                                   Roelofs J, Park S, Haas W, Tian G, McAllister FE, Huo Y, Lee BH, Zhang F, Shi Y, Gygi SP, Finley <br />                                                       D. Chaperone-mediated pathway proteasome regulatory particle assembly. Nature. 2009; <br />                                                       459:861&#226;&#8364;&#8220;865. [PubMed: 19412159] <br />                                                   Saeki Y, Toh EA, Kudo T, Kawamura H, Tanaka K. Multiple proteasome-interacting proteins assist <br />                                                       assembly yeast 19S regulatory particle. Cell. 2009; 137:900&#226;&#8364;&#8220;913. [PubMed: 19446323] <br />                                                   Shim SM, Lee WJ, Kim Y, Chang JW, Song S, Jung YK. Role S5b/PSMD5 proteasome <br />                                                       inhibition caused TNF-alpha/NFkappaB higher eukaryotes. Cell Rep. 2012; 2:603&#226;&#8364;&#8220;615. <br />                                                       [PubMed: 22921402] <br />                                                   Smith DM, Chang SC, Park S, Finley D, Cheng Y, Goldberg AL. Docking proteasomal <br />                                                       ATPases&#226;&#8364;&#8482; carboxyl termini 20S proteasome&#226;&#8364;&#8482;s alpha ring opens gate substrate entry. <br />                                                       Mol Cell. 2007; 27:731&#226;&#8364;&#8220;744. [PubMed: 17803938] <br />                                                   Smith S, Giriat  Schmitt  Lange T. Tankyrase, poly(ADP-ribose) polymerase human <br />                                                       telomeres. Science. 1998; 282:1484&#226;&#8364;&#8220;1487. [PubMed: 9822378] <br />                                                   Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization Brain 26S Proteasome                                                       Interacting Proteins. Mol Neurosci. 2010:3. [PubMed: 20407580] <br />                                                   Takagi K, Kim S, Yukii H, Ueno M, Morishita R, Endo Y, Kato K, Tanaka K, Saeki Y, Mizushima T. <br />                                                       Structural basis specific recognition Rpt1p, ATPase subunit 26 S proteasome, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       proteasome-dedicated chaperone Hsm3p. J Biol Chem. 2012; 287:12172&#226;&#8364;&#8220;12182. [PubMed: <br />                                                       22334676] <br />                                                   Tanahashi N, Kawahara H, Murakami Y, Tanaka K. proteasome-dependent proteolytic  <br />                                                       Mol Biol Rep. 1999; 26:3&#226;&#8364;&#8220;9. [PubMed: 10363639] <br />                                                   Tanaka K, Mizushima T, Saeki Y. proteasome: molecular machinery pathophysiological <br />                                                       roles. Biol Chem. 2012; 393:217&#226;&#8364;&#8220;234. [PubMed: 23029643] <br />                                                   Tomko RJ Jr, Hochstrasser M. Order proteasomal ATPases eukaryotic proteasome <br />                                                       assembly. Cell Biochem Biophys. 2011; 60:13&#226;&#8364;&#8220;20. [PubMed: 21461838] <br />                                                   Varshavsky  ubiquitin  immense realm. Annu Rev Biochem. 2012; 81:167&#226;&#8364;&#8220;176. <br />                                                       [PubMed: 22663079] <br />                                                   Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals mitochondrial AIF: key event                                                       parthanatos. Exp Neurol. 2009; 218:193&#226;&#8364;&#8220;202. [PubMed: 19332058] <br />                                                   Watanabe TK, Saito  Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil <br />                                                       KB, Chung CH, Tanahashi N, Tanaka K. cDNA cloning characterization human <br />                                                       proteasomal modulator subunit, p27 (PSMD9). Genomics. 1998; 50:241&#226;&#8364;&#8220;250. [PubMed: 9653651] <br />                                                   Yeh TY, Beiswenger KK, Li P, Bolin KE, Lee RM, Tsao TS, Murphy  Hevener AL, Chi NW. <br />                                                       Hypermetabolism, hyperphagia, reduced adiposity tankyrase-deficient mice. Diabetes. <br />                                                       2009; 58:2476&#226;&#8364;&#8220;2485. [PubMed: 19651815] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Zaiss DM, Standera S, Holzhutter H, Kloetzel P, Sijts AJ. proteasome inhibitor PI31 competes <br />                                                       PA28 binding 20S proteasomes. FEBS Lett. 1999; 457:333&#226;&#8364;&#8220;338. [PubMed: 10471803] <br />                                                   Zaiss DM, Standera S, Kloetzel PM, Sijts AJ. PI31 modulator proteasome formation                                                       antigen processing. Proc Natl Acad Sci U S  2002; 99:14344&#226;&#8364;&#8220;14349. [PubMed: 12374861] <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                  Page 14 <br />  <br />  <br />                                                                                           Highlights <br />                                                   &#226;&#8364;&#162;    TNKS modifies proteasome regulator PI31 ADP -ribosylation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   &#226;&#8364;&#162;    ADP-ribosylation alters PI31 affinity proteasome proteins <br />                                                   &#226;&#8364;&#162;    TNKS regulates 26S proteasome activity controlling assembly <br />                                                   &#226;&#8364;&#162;    TNKS-inhibitors represent new class agents block 26S assembly <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                     Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 1. dTNKS, novel interacting partner DmPI31 <br />                                                     dTNKS antiserum detects purified dTNKS. Purified FLAG-tagged dTNKS detected <br />                                                   Western blot dTNKS antiserum (lane 3), pre-immune serum (lane <br />                                                   2). (B) 0&#226;&#8364;&#8220;2h yw (WT) embryo extract used anti-DmPI31 immunoprecipitation (IP) <br />                                                   demonstrate DmPI31 interacts dTNKS vivo. (C) DmPI31:dTNKS complex <br />                                                   form mammalian 293 cells. Anti-FLAG IP experiment performed using extracts <br />                                                   293 cells expressing FLAG-tagged dTNKS HA-tagged deIF4A (negative <br />                                                   control) DmPI31. (D) Schematic representation WT mutant dTNKS                                                   respective domains. Numbers denote amino acid positions. (E) dTNKS recruits DmPI31 <br />                                                   ANK domain demonstrated IP experiment using 293 cell extracts <br />                                                   expressing HA-tagged DmPI31 FLAG-tagged dTNKSWT, dTNKS &#206;&#8221;SAM-PARP                                                   dTNKS &#206;&#8221;ANK. (F) Alignments TNKS-binding motif human 3BP2 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   (Guettler et al., 2011; Levaot et al., 2011) DmPI31 reveal presence putative <br />                                                   motif DmPI31. Numbers indicate position residues DmPI31. (G) dTNKS <br />                                                   interacts multiple DmPI31 surfaces: putative DmPI31 TNKS-binding motif <br />                                                   (RG49/54AA) conserved C-terminal residues (D211 P243) including HbYX- <br />                                                   domain. Figure S1. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                             Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 2. dTNKS post-translationally modifies PI31 ADP-ribosylation regulate 26S <br />                                                   proteasome activity <br />                                                     DmPI31 poly ADP-ribosylated vivo. Endogenous DmPI31 ADP-ribosylation                                                   detected using 0&#226;&#8364;&#8220;2h WT embryo extracts immuno-precipitated anti-DmPI31. Eluted <br />                                                   proteins analyzed Western blotting using anti-poly ADP-ribose (PAR) antibody. <br />                                                   (B) dTNKS directly ADP-ribosylates DmPI31 vitro dependent PARP <br />                                                   domain. Samples containing Biotin-NAD+, DmPI31, FLAG-dTNKSWT  <br />                                                   dTNKS &#206;&#8221;PARP analyzed ADP-ribosylation Western analysis. Input proteins <br />                                                   analyzed Western blotting (right panel). (C D) Tools used investigate <br />                                                   role TNKS 26S proteasome regulation. (C) XAV939 inhibits Drosophila TNKS <br />                                                   (dTNKS) vitro, indicating activity drug conserved species. (D) <br />                                                   siRNAs targeting hTNKS1 hTNKS2 efficiently knocked expressions 293 cells. <br />                                                   &#206;&#177;-tubulin used loading control. (E F) TNKS inhibition XAV939 reduces <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome activity Drosophila embryo (E) 293 cell (F) extracts. (G) Reduced <br />                                                   hTNKS1 hTNKS2 levels inhibit 26S proteasome activity. (E&#226;&#8364;&#8220;G) Data presented                                                   mean &#194;&#177; standard deviation independent experiments. Values obtained DMSO <br />                                                   (E&#226;&#8364;&#8220;F) control siRNA (G) set 100%. (E) *, p=0.01; (F) *, p=0.05; (G) *, p=0.04 <br />                                                   **, p=0.006. Statistical analysis performed tailed, paired, t-test.                                                   Figure S2. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                       Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 3. dTNKS dp27 RNAi enhances compromised proteasome activity <br />                                                   test dTNKS dp27 role modulating proteasome activity vivo, expressed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   RNAi dTNKS (21930, 21932 106238; C&#226;&#8364;&#8220;E) dp27 (28527, 47762                                                   47763; F&#226;&#8364;&#8220;L) background dominant-negative temperature sensitive mutants (UAS- <br />                                                   DTS5 UAS-DTS7) 29&#194;&#176;C. expected, regulation factors resulted                                                   significant enhancement mutant rough reduced eye phenotype (compare panels B                                                   C&#226;&#8364;&#8220;L) dp27 RNAi lines, caused male lethality. observations indicative <br />                                                   reduced proteasome activities tissues. GMR-Gal4 expression caused                                                   discernable eye defects (panel . Orientation eyes anterior left dorsal  <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                       Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 4. ADP-ribosylation relieves 20S inhibition PI31 <br />                                                     DmPI31 interacts 20S proteasomes select &#206;&#177;-subunits: &#206;&#177;1, &#206;&#177;3, &#206;&#177;4 &#206;&#177;6. (B) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   ADP-ribosylation significantly decreases affinity DmPI31 &#206;&#177;4. FLAG- &#206;&#177;4 <br />                                                   expressing 293 cell extract incubated modified DmPI31  DmPI31ADPR) test <br />                                                   effect &#206;&#177;4:DmPI31 complex. Chemoluminescence quantitated using <br />                                                   ImageQuant LAS-4000 (GE Healthcare). &#206;&#177;4-binding reported relative                                                   immunoprecipitated DmPI31 compared level input DmPI31. (C) <br />                                                   Modification DmPI31 relieves inhibitory effect 20S proteasomes. Purified bovine <br />                                                   20S proteasomes (0.1 &#206;&#188;g) incubated DmPI31 DmPI31ADPR proteins <br />                                                   (2 &#206;&#188;g , chymotrypsin-like proteasome activity measured. Data presented                                                   mean &#194;&#177; standard deviation independent experiments. value obtained 20S <br />                                                   proteasome set 100%. *, p=0.04, **, p=0.6 ***, p=0.045. Statistical analysis                                                   performed tailed, paired, t-test. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                         Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 5. TNKS PI31 regulate proteasome assembly <br />                                                     Inhibition dTNKS XAV939 led drastic shift proteasome profile                                                   &#226;&#8364;&#339;lighter&#226;&#8364;? fractions, indicative reduced 26S particles. assess effect                                                   TNKS activity 26S assembly, embryo extracts treated XAV939 subjected                                                   Superose 6 gel filtration chromatography. (B) TNKS inhibition severely affects 26S <br />                                                   proteasome assembly. effect XAV939 proteasome assembly embryo extracts <br />                                                   assessed native gel analysis. (C) Similar XAV939, surplus DmPI31 dramatically <br />                                                   affected proteasome assembly. Furthermore, caused i <br /> </body></html>